echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > European Medicines Agency: mRNA new crown vaccine is not associated with autoimmune hepatitis

    European Medicines Agency: mRNA new crown vaccine is not associated with autoimmune hepatitis

    • Last Update: 2022-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a study on "New crown vaccine may cause a rare T cell-mediated autoimmune hepatitis" published in the Journal of Hepatology, a journal in the field of liver disease The paper, which was finalized on March 31, 2022, refers to a case report in Germany of a 52-year-old man who developed a bimodal flare of acute hepatitis after receiving 2 doses of the mRNA vaccine


    In this regard, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) announced on April 8 that there is currently no evidence to support a causal relationship between the mRNA new crown vaccine and autoimmune hepatitis (AIH), and no update is currently required.


    There is currently no evidence to support a causal relationship between the mRNA new crown vaccine and autoimmune hepatitis (AIH), and there is currently no need to update the product information for the vaccine


    Autoimmune hepatitis (AIH) is a very rare chronic progressive liver inflammatory disease mediated by an autoimmune response, according to the PRAC meeting minutes


    The European Medicines Agency (EMA) said it will continue to closely monitor any new situation reports and take appropriate measures if necessary


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.